Skip to main content
. 2023 Jun 27;14(9):1471–1479. doi: 10.1007/s13300-023-01437-x

Table 2.

Serial change in HbA1c (%) during the study period

Time point Empagliflozin (n = 154), % Insulin (n = 147), % P value
Baseline 8.9 ± 1.0 9.0 ± 1.4 NS
Month 3 7.4 ± 0.5 7.8 ± 1.7 < 0.01
Month 6 7.3 ± 0.8 7.5 ± 1.5 < 0.01
Month 12 7.4 ± 0.8 8.0 ± 1.4 < 0.01
Month 18 7.4 ± 0.9 8.0 ± 1.3 < 0.01
Month 24 7.5 ± 1.0 7.8 ± 1.2 NS
Month 30 7.4 ± 0.9 7.8 ± 1.1 NS
Month 36 7.4 ± 0.8 8.0 ± 1.4 < 0.05

Data are expressed as mean ± (SD). For tests of between-group differences, the paired t-test was performed at each time point. P values are expressed as either < 0.05, < 0.01, or NS (non-significant)